SPONSOR
Shanghai Institute Of Biological Products
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced Tumors
Shanghai Institute Of Biological Products is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Tumors.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Institute Of Biological Products
How many clinical trials has Shanghai Institute Of Biological Products sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Shanghai Institute Of Biological Products, of which 1 are actively recruiting participants. These trials cover conditions including Advanced Tumors. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Institute Of Biological Products research focus on?
Shanghai Institute Of Biological Products clinical trials span Advanced Tumors. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Institute Of Biological Products clinical trial?
To participate in a Shanghai Institute Of Biological Products trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Institute Of Biological Products trials with current recruitment status updated daily.
Clinical Trials by Shanghai Institute Of Biological Products
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology